Operating medical facilities with Japanese standards of quality, safety, and patient-centered care.
Creating high-quality health supplements backed by scientific research and compliant with strict regulations.
Connecting global healthcare resources through technology transfer, specialist exchanges, and international treatment networks.
With cross-border healthcare expertise, the company acts as a strategic bridge between China and Japan, driving efficient and value-focused collaboration.
To promote practical clinical collaboration between China and
Japan, Tokyo Daiwa initiates and continuously
supports the China-Japan distinguished physicians medical
exchange academic platform.
It regularly convenes
experienced specialists in internal medicine, oncology,
regenerative medicine, and preventive medicine from leading
universities, general hospitals, and specialized institutions.
Through focused seminars, case studies, and technical exchanges
in an open and pragmatic atmosphere, the conference facilitates
mutual learning of the latest advances in precision oncology,
stem cell and regenerative therapies, chronic disease
management, and preventive strategies.
This enables
physicians in both countries to swiftly and appropriately
integrate effective new techniques and concepts into routine
practice, enhancing healthcare quality and patient outcomes
through an efficient, professional non-governmental channel.
Japan Clinic M&A and Management Services provides
comprehensive one-stop solutions tailored for Chinese and other
Asian investors seeking to acquire, partner with, or operate
medical clinics in Japan.
Our professional team
offers end-to-end support covering target screening, due
diligence, valuation, negotiation, regulatory compliance,
transaction structuring, post-merger integration, and ongoing
clinic operations management.
With deep expertise in
Japan’s healthcare regulations, licensing requirements,
physician recruitment, and localized operational best practices,
we help investors efficiently enter or expand in the Japanese
medical market, ensuring smooth ownership transitions,
sustainable profitability, and high-quality patient care
standards.
Cross-Border Healthcare Collaboration connects Japan’s advanced
medical resources with China’s vast healthcare demand market to
drive deep bilateral cooperation in the medical industry.
We
facilitate partnerships in specialty hospitals, diagnostic
centers, telemedicine, medical tourism, technology transfer, and
joint R&D projects. By bridging regulatory frameworks,
clinical standards, and business models between the two
countries, we help Japanese medical institutions expand into
China and enable Chinese partners to introduce proven Japanese
technologies, management expertise, and high-quality care
models.
This platform promotes sustainable, win-win
collaboration that elevates clinical outcomes, accelerates
innovation, and delivers premium healthcare services across
borders.